The p21-activated kinase (PAK) family of protein kinases has recently attracted considerable attention as an eector of Rho family of small G proteins and as an upstream regulator of MAPK signalling pathways during cellular events such as re-arrangement of the cytoskeleton and apoptosis. We have cloned a novel human PAK family kinase that has been designated as PAK5. PAK5 contains a CDC42/Rac1 interactive binding (CRIB) motif at the N-terminus and a Ste20-like kinase domain at the C-terminus. PAK5 is structurally most related to PAK4 and PAK6 to make up the PAK-II subfamily. We have shown that PAK5 preferentially binds to CDC42 in the presence of GTP and that CRIB motif is essential for this interaction. PAK5 is a functional protein kinase but unlike PAK-I family kinases (PAK1, 2, and 3), the kinase activity of PAK5 does not seem to require the binding of CDC42. Overexpression of PAK5 activates the JNK kinase pathway but not p38 or ERK pathways. PAK5 transcript is predominantly expressed in brain as revealed by Northern blot and in situ hybridization. The expression pattern of PAK5 is distinct from that of PAK4 and PAK6, suggesting a functional division among PAK-II subfamily kinases based on dierential tissue distribution.
Introduction
The importance of p21 activated kinase (PAK) family of kinases has become increasingly realized in cellular signalling pathways. As eectors of the Rho family of small GTP-binding proteins, Rac and CDC42, PAK family kinases (PAKs) participate in various facets of cellular events. In addition to modulating the organization of the actin cytoskeleton to control cell morphology and motility, PAKs activate mitogen-activated protein kinase (MAPK) signalling pathways to aect gene expression (Sells and Cherno, 1997; Bagrodia and Cerione, 1999) . More recently, PAKs have also been implicated in apoptosis and have been shown to possess either pro-apoptotic or anti-apoptotic properties in dierent studies (Rudel and Bokoch, 1997; Schurmann et al., 2000 , Tang et al., 2000 , Jakobi et al., 2001 , Gnesutta et al., 2001 .
The PAK family together with the GCK (germinal centre kinase) family comprises the Ste20 (Sterile20) group of kinases in higher eukaryotes. They all share an evolutionarily conserved Ste20-like kinase domain. However, the PAK family members are distinguished from GCK family kinases in that they have a kinase domain at their C terminus instead of at the N terminus. A total of six PAK family members has been identi®ed thus far in humans, including PAK5 reported in this paper. They have been sequentially numbered from 1 to 6. Recent extensive analysis based on human, Drosophila and C. elegans genomic sequences has revealed that the PAK family can be classi®ed into two distinct subfamilies. The PAK-I subfamily consists of three mammalian kinases PAK1, 2 and 3 together with their Drosophila and C. elegans orthologs, DPAK and CePAK (C09B8.7), while PAK-II subfamily consists of three mammalian kinases PAK4, 5 and 6 together with their Drosophila and C. elegans orthologs, mushroom bodies tiny (MBT) and C45B11.1, respectively (Dan et al., 2001) .
All PAK family kinases share two common structural features: a kinase domain at the C-terminus and a CDC42/Rac-interactive-binding (CRIB) domain in the middle of the N-terminal non-catalytic region. The PAK-I subfamily kinases have some additional characteristic motifs. The ®rst is an auto-inhibitory domain located downstream of the CRIB domain which partially overlaps with the CRIB domain itself. PAK-Is are inactivated by intramolecular interaction of the auto-inhibitory domain with the kinase domain.
The binding of CDC42 or Rac to the CRIB domain disrupts this interaction, leading to the activation of the kinase activity. The second is a Cool/Pix-binding motif, which is crucial for the recruitment of PAK-Is to focal adhesion complexes upon stimulation by CDC42/ Rac-1. In addition, proline rich motifs implicated in the binding of SH3 domain-containing adapter proteins such as Nck, are present at the extreme Nterminal region, while the C-terminal region is implicated as a binding site for the b subunit of heterotrimeric G-proteins. PAK-Is are highly homologous to the yeast Ste20p, sharing both CRIB and auto-inhibitory domains (Sells and Cherno, 1997; Bagrodia and Cerione, 1999; Dan et al., 2001) . These kinases are so highly conserved that PAK3 from humans is able to complement Ste20p defects in the budding yeast (Bagrodia et al., 1995a) .
Subfamily II PAK members have a CRIB domain without a recognizable auto-inhibitory domain, and they lack binding motifs for Cool/Pix, Nck and Gb (Sells and Cherno, 1997; Bagrodia and Cerione, 1999; Dan et al., 2001) . Function of PAK-IIs is only beginning to be understood. PAK4, the only PAK-II member characterized in detail thus far, is involved in reorganization of the actin cytoskeleton in a manner that is distinct from that of PAK-Is. Unlike PAK-Is, the kinase activity of PAK4 is not dependent on Rho family GTPases. CDC42 can bind to PAK4 but is involved in the translocation of PAK4 to the Golgi apparatus, rather than its activation (Abo et al., 1998) . PAK4 has been shown to induce ®lopodia formation through the re-arrangement of the cytoskeleton, but its regulatory mechanism remains uncertain. Recently, X-PAK5, a novel PAK-II kinase in Xenopus laevis, was demonstrated to bind to actin and microtuble networks (Cau et al., 2001) . Because X-PAK5 is most related to human PAK4 and more distantly to PAK5 and PAK6, it is likely to be the Xenopus laevis ortholog of human PAK4. It has been suggested that X-PAK5 dissociates from microtubules upon catalytic activation, and subsequent binding to CDC42/Rac1 GTPases causes it to translocate to actin cytoskeleton such as stress ®bres and lamellipodia (Cau et al., 2001 ). An entirely novel functional role has been assigned to recently cloned PAK6 despite its structural similarity to other PAK-IIs. PAK6 is preferentially expressed in testis and binds the androgen receptor. In response to androgen, it translocates to the nucleus resulting in repression of androgen receptor-mediated transcription (Yang et al., 2001) .
Drosophila ortholog of PAK-IIs, MBT, is suggested to play integral roles in neuronal morphogenesis since its de®ciency results in severe defects in central brain structures in adult¯ies. Flies with mutations in mbt gene remain viable but have severe defects in generation or survival of the intrinsic cells known as Kenyon cells of mushroom bodies in the brain (Melzig et al., 1998) . This study suggested that one of the mammalian PAK-IIs may also participate in the morphogenesis of brain structures. A pre-requisite for such an involvement is expression in brain. PAK4 is ubiquitously expressed in most tissues, while PAK6 is speci®cally expressed in testes and prostate (Abo et al., 1998; Yang et al., 2001) . In Ste20 group kinases, functional division among subfamily members is often established by dierential expression patterns. Therefore, it has been anticipated that there exists a human PAK-II kinase that may be speci®cally expressed in brain.
In search of the missing member of the PAK-II subfamily, we have cloned a novel kinase of the PAK-II subfamily, PAK5. In this paper, we show that PAK5 is predominantly expressed in brain. PAK5 is a protein kinase that activates JNK (Jun N-terminus kinase) but not p38 or ERK (extracellular signal-regulated kinase). PAK5 interacts with CDC42 and this interaction is mediated by the CRIB motif in the N-terminus. Unlike the case with PAK-Is, the binding of CDC42 is not necessary for the kinase activity of PAK5.
Results and discussion

Cloning of PAK5
The existence of the PAK5 gene in the human genome was ®rst pointed out in our systematic phylogenetic analysis of the PAK family of kinases (Dan et al., 2001) . While the PAK-I subfamily of kinases consists of three paralogs in the human genome, only one member, PAK4, had been found for the PAK-II subfamily. In searching for additional molecules related to PAK-4, we performed RT ± PCR (reverse transcription polymerase chain reaction) using degenerate primers. The design of these primers was based on a conserved CRIB motif and kinase domain of PAK4 (Abo et al., 1998) . From total RNA of adult human brain, we ®rst obtained a 1.7 kb cDNA fragment. A sequence analysis of the fragment revealed that it encoded a novel PAK4-like kinase. Since this clone did not contain the entire open reading frame, 5' and 3' RACE (rapid ampli®cation of cDNA ends) experiments were performed in order to obtain a longer insert. The longest clone we obtained harbors a 4612 bp insert containing an open reading frame of 719 amino acids with the initiator methionine following a 380 bp-long 5' UTR (untranslated region) with multiple in-frame stop codons (Figure 1a ). Another cDNA entry in the database (KIAA1264; GenBank accession no. AB033090) (Nagase et al., 1999) contains an additional 34 amino acid residues as compared to our protein sequence with the start codon annotated as not identi®ed.' We have reported earlier that comparative genomic analysis is a valid method to assign the start codon in such cases (Peri and Pandey, 2001) . Therefore, based on a multiple alignment of coding regions of all known PAK family kinases from several species, we have assigned the start codon as shown in Figure 1a . Since the encoded protein sequence was most homologous to PAK4 as well as related to PAK1, 2, and 3, we have designated it as PAK5.
Sequence analysis of PAK5
The C-terminal region of PAK5 encodes a Ste20-like kinase domain comprising of 11 kinase subdomains (Figure 1a ) (Hanks and Hunter, 1995) . The conserved motif called Ste20 signature sequence that is highly conserved in all Ste20 group kinases is also present in PAK5 (Dan et al., 2001) . The kinase domain of PAK5 is most closely related to that of PAK-II subfamily kinases ± PAK4 (85% identity), PAK6 (80%), Drosophila MBT (82%), and C. elegans putative kinase C45b11.1 (62%) (Abo et al., 1998; Yang et al., 2001; Melzig et al., 1998) . It is also more distantly related to members of the PAK-I subfamily with 52 ± 57% identity to mammalian PAK1, 2, and 3 together with Drosophila DPAK, C. elegans CePAK (also known as C09B8.7), and also to the budding yeast Ste20p (Sells and Cherno, 1997; Bagrodia and Cerione, 1999) . PAK5 is moderately related to other GCK family kinases (less than 50%) in its kinase domain (Dan et al., 2001) .
The other signi®cant feature of PAK family kinases is the presence of CRIB motif at the N-terminus (Figure 1a) . The CRIB motif of PAK5 is most homologous to that of PAK-IIs (63 ± 81% identities) and moderately homologous to that of PAK-Is (57%). The region that follows the CRIB-motif that has been shown as an auto-inhibitory domain for PAK-I subfamily kinases is not observed in PAK5 (Sells and Cherno, 1997; Bagrodia and Cerione, 1999; Dan et al., 2001) . However, the region approximately 6 amino acids downstream of the CRIB motif of PAK5 is conserved among all PAK-II family kinases. Thus this region might be responsible for unidenti®ed steric regulation modulated by interaction with small-G proteins. Other motifs conserved among mammalian PAK-Is such as Nck binding motif, Cool/Pix binding motifs, and Gb-binding motif are not found in PAK5 (Sells and Cherno, 1997; Bagrodia and Cerione, 1999; Dan et al., 2001) . The extreme N terminal region of PAK5 forms a basic box that is conserved among PAK-II subfamily kinases. Taking the observation that PAK6 translocates to the nucleus upon stimulation by androgens into consideration, this conserved basic box may function as a nuclear localisation signal under certain conditions (Yang et al., 2001) . A DNA database search revealed that the human PAK5 gene is encoded by the region of contiguous human genomic sequence NT011387 from chromosome 20 that consists of ®ve contiguous BAC (bacterial arti®cial chromosome) clones RP4-707M17 (AL034427), RP5-873P14 (AL031682), RP11-193E12 (AL135934), RP5-986117 (AL353612) and RP5-1119D9 (AL031652). Comparison of PAK5 cDNA sequence with human genomic sequence revealed that the human PAK5 gene spans over 300 kb of genomic DNA. PAK5 gene is encoded by 12 exons in the region 20p12 of the human genome ( Figure 1b ). All exon/ intron boundaries matched the consensus sequences for splicing (data not shown). A CpG island of approximately 1 kb is found in the upstream region of PAK5 locus (approximately nt 6050000 ± 6051000 of NT011387). This CpG island extends from the region upstream to exon 1 to the upstream part of the ®rst intron. The 5'UTR region of the PAK5 gene is alternatively spliced to yield two dierent transcripts; one consisting of all 12 exons and another without the second exon. The PAK5 cDNA that we have cloned lacks the second exon while another entry in the database (KIAA1264; GenBank accession no. AB033090) contains all the twelve exons. Since both these forms encode the same protein, the physiological signi®cance of this dierential splicing event in the 5'UTR of PAK5 is not known. An additional cDNA entry corresponding to human PAK5 that has recently been deposited (GenBank accession no. AAH24179) is mistakenly designated as PAK7 clearly indicating the need for careful database searching before depositing potentially novel sequences.
Tissue distribution of PAK5 mRNA
We examined the expression pattern of the PAK5 mRNA by probing a multiple tissue Northern blot (Figure 2a) . A single band of approximately 5 kb was detected predominantly in the brain. Thus the 4612 bp clone we have ampli®ed from brain is likely to have originated from the 5 kb PAK5 transcript. To investigate regional speci®city of PAK5 expression in brain, we examined PAK5 mRNA expression in the adult mouse brain by in situ hybridization ( Figure  2b ,c). The mouse PAK5 cDNA fragment corresponding to nt 2860 ± 3590 of human PAK5 was obtained by RT ± PCR and an antisense and a sense ribonucleotide probe were generated. PAK5 mRNA was expressed throughout all regions of the brain, with higher levels of expression detected in the cerebellum, cerebral cortex and olfactory bulb. In cerebellum, discrete and intense signals were detected in the granular cell layer, while basal level of expression was detected in Purkinje and molecular cell layers (data not shown). We also examined PAK5 mRNA expression in the E13 embryonic mouse brain. As in the adult brain, PAK5 transcript was abundant in cerebral cortex and olfactory bulb (Figure 2d ,e). Striatum and midbrain also showed high levels of PAK5 mRNA expression. In contrast to the rather high PAK5 expression in the adult mouse cerebellum, only negligible level of expression was detected in cerebellar primordium of mouse embryo. Since cerebellar development is the slowest process in the development of brain, only its immature primordium is present at this stage suggesting that PAK5 is preferentially expressed in mature neural systems rather than in developing ones.
The brain speci®c expression of PAK5 is in marked contrast to the expression patterns of other PAK-II members, PAK4 with ubiquitous expression and PAK6 with reproductive organ-speci®c expression. This dierential pattern of expression among PAK-II subfamily kinases implies a functional division among them. Especially noteworthy in this context is the brain speci®c expression of PAK5 since their common ortholog in Drosophila (MBT) plays an essential role in adult brain development (Melzig et al., 1998) . It is plausible that one of the PAK-IIs has a similar function in mammalian brain development. Our results show that PAK5 is abundant in the brain structures that are in relatively later stages of development in mouse embryo. Notably, PAK5 was only present in adult cerebellum but not in its primordium in the embryo. These results suggest that PAK5 may function in the mature brain or in later stages of developing brain.
PAK5 cDNA encodes an 80 kD protein
The ability of PAK5 cDNA to code for the corresponding protein was tested by transfecting a Myc epitope-tagged version of the cDNA into 293T cells. Vector alone was transfected as a negative control. Western blotting using an anti-Myc antibody detected a band migrating at approximately 80 kDa which is consistent with its predicted molecular weight (Figure 3a) .
Interaction of PAK5 with Rho family small GTPases
The presence of a CRIB motif in PAK5 suggests that PAK5 can function as a target for the Rho family GTPases such as Rac1 and CDC42 (Sells and Cherno, 1997; Bagrodia and Cerione, 1999; Dan et al., 2001 , Frost et al., 1997 Bagrodia et al., 1995b; Zhang et al., 1995) . To examine if PAK5 interacts with any of these small G-proteins, we performed pull-down assays using GST (glutathione S-transferase) fusion proteins. Cell lysates from 293T cells transfected with wild-type (WT) PAK5 were incubated with GST ± CDC42, GST ± Rac1 or GST ± RhoA. Glutathione-sepharose beads were used to isolate the GST fusion proteins followed by Western blotting to detect the coprecipitating PAK5. As shown in Figure 3b , PAK5 interacted with GST ± CDC42 but not with Rac1 or RhoA.
To further examine whether the interaction of PAK5 to CDC42 is dependent on GTP, we performed a GST ± CDC42 pull-down assay in the presence and absence of GTP. GST ± CDC42 was able to pull down WT PAK5 in the presence of GTP, but not in its absence (Figure 3c ). These results demonstrate that PAK5 preferentially binds to GTP-loaded form of CDC42. To assess whether the interaction of PAK5 and CDC42 is mediated by the CRIB-motif, we performed a similar analysis using the DCRIB mutant of PAK5. No interaction between DCRIB mutant of PAK5 and CDC42 in the presence or absence of GTP was observed indicating that the CRIB motif of PAK5 is essential for its interaction with CDC42 (Figure 3c) . We also performed coimmunoprecipitation experiments to examine if PAK5 and CDC42 interact in vivo. For this purpose, 293T cells were cotransfected with expression vectors for epitope-tagged WT or activated CDC-42 either with WT or the DCRIB version of PAK5. As shown in Figure 3d , only WT PAK5 interacted with CDC-42 in vivo and this interaction was enhanced when an activated version of CDC42 was used.
Thus we have shown that PAK5 can only bind to CDC42 but not to Rac1 or RhoA. This feature is also shared by PAK4, which can bind strongly to CDC42, weakly to Rac1 and not at all to RhoA (Abo et al., 1998) . The interaction of PAK6 with small G-proteins has not yet been demonstrated, but the high degree of conservation of the CRIB motif among the three kinases suggests that preference for CDC42 is likely to be their shared feature.
PAK5 undergoes autophosphorylation and phosphorylates MBP
The kinase activity of PAK5 was next tested by overexpression of vector or WT PAK5 in 293 cells and immunoprecipitation with anti-Myc antibody followed by an in vitro kinase assay using MBP (myelin basic protein) as an exogenous substrate. A strongly phosphorylated band corresponding to MBP was detected in the WT PAK5 transfected lane but not in vector control (Figure 4) . Also, a band corresponding to WT PAK5 was observed indicating that it is Expression of PAK5 mRNA in a sagittal section of the E13 mouse embryo detected by in situ hybridization using DIG-labelled antisense ribonucleotide probe. (e) A sagittal section of the E13 mouse embryo stained by DIG-labelled sense ribonucleotide probe as a negative control. Abbreviations used are: CB, cerebellum; CC, cerebral cortex; HC, hippocampus; IC, inferior colliculus; M, medulla; OB, olfactory bulb; P, pons; SC, superior colliculus; ST, striatum; TH, thalamus; mb, midbrain; cp, cerebellar primordium Oncogene A novel p21-activated kinase, PAK5 A Pandey et al capable of undergoing autophosphorylation. To further con®rm that the kinase activity is attributable to PAK5, we introduced several mutations into PAK5 cDNA in order to obtain a kinase-dead version of PAK5. Since PAK5 possesses two lysine residues in tandem within its ATP binding pocket, we created two mutants ± one with a substitution of the lysine in position 479 with methionine (PAK5 K478M) and the other containing a substitution of both the lysine residues with methionine residues (K478M+K479M) (Hanks and Hunter, 1995) . Additionally, two residues that are generally conserved in the activation loop between kinase subdomains 7 and 8 and activate kinase activity upon phosphorylation were also mutated (S602M+T606M). For unknown reasons, all of these mutants were weaker in their expression levels in 293 cells as compared to WT PAK5 (data not shown). To compensate for this lower expression, a larger amount of the immunoprecipitate of the mutants compared to WT PAK5 was used for normalization. As shown in Figure 4 , signi®cant reductions of phosphorylation toward PAK5 itself and toward MBP were observed. Slight negligible phosphorylation was still observed but this may be by co-immunoprecipitated proteins due to higher input. Taken together, these results demonstrate that PAK5 cDNA encodes a functional kinase.
In contrast to PAK-I subfamily kinases that require binding of Rac1 or CDC42 for their kinase activity, PAK5 seems to become constitutively active upon overexpression. To exclude the possibility that PAK5 activation is apparently achieved by co-immunoprecipitated endogenous CDC42, we introduced a DCRIB mutant form of PAK5 that is unable to interact with CDC42. The DCRIB mutant PAK5 was as active as WT PAK5 (Figure 4 ). This result demonstrates that activation of PAK5 does not require CRIB motif and is likely to be independent of CDC42.
Activation of JNK by PAK5
Because several members of PAK family of kinases have been reported to activate one or more MAP kinases (Sells and Cherno, 1997; Bagrodia and Cerione, 1999; Dan et al., 2001 , Frost et al., 1997 Bagrodia et al., 1995b; Zhang et al., 1995) , it was possible that PAK5 may also activate MAPK pathways. To test this possibility, we examined the ability of PAK5 to activate any of MAPKs. 293 cells were cotransfected with WT PAK5 and Flag epitope-tagged JNK1 or p38 constructs. The respective MAPKs were immunoprecipitated and subjected to in vitro kinase assays. As shown in Figure 5a , both WT PAK5 and the DCRIB mutant (which cannot interact with CDC42) resulted in the activation of JNK. These results indicate that, as in the case with autophosphorylation and phosphorylation of MBP, the CRIB motif was not required for activation of JNK kinase. Although this result does not strictly exclude the possibility that PAK5 activates JNK as an eector of CDC42, we conclude that CDC42 binding is not In order to compensate for extremely low level of expressions of the kinase mutants, 5 ± 10 times as much immunoprecipitates of the kinase-dead samples as those of WT PAK5, DCRIB PAK5 were used for the assays Figure 5 PAK5 activates JNK but not p38 kinase. (a) JNK kinase assay. 293 cells were cotransfected with vector control, WT PAK5 or DCRIB PAK5 constructs as indicated together with a FLAG-tagged JNK construct. Cell lysates were immunoprecipitated with anti-FLAG antibody and assayed for JNK kinase activity using [g-32 P]-labelled ATP and GST ± ATF2 as substrate. The reaction products were separated by SDS ± PAGE and scanned by a phosphorimager. The top panel shows the phosphorimager scan of the gel. The bottom panel shows an anti-FLAG Western blot of the lysates to con®rm equal amounts of JNK. (b) p38 kinase assay. 293 cells were cotransfected with the indicated constructs and a FLAG-tagged p38 version. Immunoprecipitation and kinase assays were performed as in panel a
Oncogene A novel p21-activated kinase, PAK5 A Pandey et al required for PAK5 to activate JNK. However, when activation of p38 was examined, we did not detect any increase in activity although interleukin-1 induced potent activation of this pathway (Figure 5b ). We also tested ERK2 and did not observe any activation upon overexpression of PAK5 (data not shown).
After this manuscript was submitted, another group reported a similar functional analysis of PAK5 (Dan et al., 2002) . While we have studied the genomic organization and mRNA expression of PAK5 in greater detail, Dan et al. (2002) have elucidated its ability to promote ®lopodia formation and neurite outgrowth in neuroblastoma cells. Our results concerning the activation of JNK pathway are in agreement with those obtained by Dan et al. (2002) in their study.
Conclusions
In conclusion, we have identi®ed and cloned a novel PAK family kinase, PAK5, that belongs to the PAK-II subfamily. Like other kinases in the subfamily, it preferentially binds to CDC42 in a GTP dependent manner and the binding of CDC42 does not aect the kinase activity of PAK5. PAK5 activates JNK but the binding of CDC42 to PAK5 is not necessary for JNK activation. Since PAK5 is predominantly expressed in the brain, it may be regarded as the most likely candidate among mammalian PAK-II subfamily members that inherits the function of Drosophila MBT in the adult brain development. These ®ndings present an important step in elucidating the functions of PAK5 and other PAK-II subfamily kinases, which are only beginning to be understood.
Materials and methods
Screening and cloning of PAK5
In order to identify additional members of the PAK5 subfamily kinases, we ®rst designed a degenerate set of primers based on human PAK4 mRNA sequence. The following were generated as forward primers; CRIB-1F: 5'-ATHWSNGCNWSGAAYTTYGARCA-3', CRIB-2F: 5'-CAYMGNGTNCAYACNGGNTTYGA-3', and CRIB-3F: 5'-GARCARAARTTYACNGGNYTNCC-3'. As the reverse primers, the following were generated; KINASE-1R: 5'-GTNGCDATRCANACDATNCCNGT-3', KINASE-2R: 5' -TCNCKCATDATNACNACYTCRTT -3', KINASE-3R: 5' -NGCNGCDATYTGYTCYTCYTCRTTCAT -3', KIN-ASE-4R: 5'-NACYTGNGCRCARAANCCRAARTC-3', KI-NASE-5R: 5'-YTCNGGNGCCATCCARTANGGNGT-3', and KINASE-6R: 5'-RTTRAARTANGGNGGYTCNCCR-TC-3', where N stands for A, C, G and T, R for A and G, Y for C and T, W for A and T, and S for C and G. Total RNA from adult human brain (Clontech, Palo Alto, CA, USA) was used as template in an RT ± PCR reaction using SuperScript II and Takara Ex DNA polymerase (Takara, Otsu, Japan) according to published methods (Dieenbach and Dveksler, 1995) . PCR was performed using all combinations of forward and reverse primers that are described above. The longest clone contained an insert of 1.7 kb clone that encoded part of the coding region of a novel PAK4-like gene. From this 1.7 kb fragment, additional primers were designed for 5' and 3' RACE; PAK5 ± 5RACE-1R: 5'-GCCTGGACCGTGGCT-GGAGGCTCCCTGATC-3', PAK5 ± 5RACE-2R: 5'-GGAA-TACTGGGAG AAGGT GATG AAGCCATT -3', PAK5 ± 5RACE-3R: 5' -GGTCGTGTAGTCAGCAGTAGTATCG-GATTC-3', PAK5 ± 3RACE-1F: 5'-GGGTACCACAAAGC-CACCTTGTACCATCAC-3', PAK5 ± 3RACE-2F: 5'-CT-GCAGAGCAGTTCGCAGTACATCTCCACG-3', PAK5 ± 3RACE-3F: 5'-ATCGCCACCGAGAAACACACAGGGA-AACAA-3'. 5' and 3' RACE were performed as published (Dieenbach and Dveksler, 1995) . The gene fragments were then assembled to represent a full-length PAK5 cDNA. One full-length clone of 4612 bp was sequenced completely on both stands. All the PCR artifacts were excluded by comparing at least three independent clones.
cDNAs and constructs
The coding region of the wild-type PAK5 cDNA was subcloned into a pcDNA 3.1 Myc/His vector (Invitrogen, Carlsbad, CA, USA) by a standard PCR-mediated method using Pfx DNA polymerase (Life Technologies, Gaithersburg, MD, USA) (Dieenbach and Dveksler, 1995) . This clone served as a Myc-tagged WT PAK5 and was used as a template for construction of mutants using a standard PCRmediated method (Dieenbach and Dveksler, 1995) . For generation of DCRIB PAK5 mutant, the CRIB motif peptide sequence from I11 to L43 (ISGPSNFEHRVHTGFDP-QEQKFTGLPQQWHSLL) was deleted and substituted with VD (GTCGAC). Three mutants, PAK5 K478M, K478M+K479M and S602M+T606M were generated to create kinase-dead versions of PAK5. The mutant clones were veri®ed by sequencing to eliminate PCR artifacts. GST ± CDC42, GST ± Rac1, GST ± RhoA constructs were generated from constructs that have been described earlier (Khosravi-Far et al., 1995) . V5-tagged JNK1 was purchased from Invitrogen (Carlsbad, CA, USA). MBP and GST ± ATF2 (activating transcription factor 2) were purchased from Upstate Biotechnology (Lake Placid, NY, USA).
Northern blot
A human multiple tissue Northern blot (Ambion, Inc., Austin, TX, USA) containing immobilized poly A + mRNA was used. A660 bp KpnI/BamHI fragment from a unique region of human PAK5 cDNA was used as a probe. The probe DNA was labelled with [a- 32 P] dCTP (Amersham Pharmacia) using the random primed labelling kit (Roche Diagnostics, Mannheim, Germany). Hybridization and washing steps were performed according to the manufacturer's instructions. The membranes were later stripped and reprobed with a beta actin probe.
In situ hybridization
Paran embedded sections of adult mouse brain and E13 mouse embryos were prepared and 7 ± 9 mm thick sections were cut and mounted on poly-L-lysine-coated slides.
For generation of a ribonucleotide probe, a fragment of mouse PAK5 (corresponding to nt 2860 ± 3590 of human PAK5, accession no. AB040812) was ampli®ed by RT ± PCR using mPAK5 ± Kpn I F: 5'-GGGGTACCACATAGGA-TTTTCTATATTGAA-3' and mPAK5 ± EcoRI R: 5'-GG-AATTCGATACCAGTGACGGCCAAAACCA-3' primers. The fragment was ligated into EcoRI and KpnI sites of pSPT18 vector (Roche Diagnostics, Mannheim, Germany) to generate sense and antisense ribonucleotide probes using SP6 and T7 RNA polymerase according to a manufacturer's protocol (Roche Diagnostics, Mannheim, Germany). For hybridization, sections were deparanized and rehydrated by sequential incubations in xylene at room temperature for 10 min (three times), DEPC-treated 100% ethanol at room temperature for 15 s, DEPC-treated 90% ethanol at room temperature for 15 s, DEPC-treated 80% ethanol at room temperature for 15 s, DEPC-treated 70% ethanol at room temperature for 15 s, DEPC-treated PBS at room temperature for 15 min, 1 mg/ml proteinase K (Takara, Otsu, Japan) in 10 mM Tris-Cl, 1 mM EDTA, pH 8.0 at room temperature for 5 min, 4% paraformaldehyde in PBS at room temperature for 10 min, DEPC-treated PBS at room temperature for 3 min, and DEPC-treated water at room temperature for 3 min. The sections were acetylated in 1% acetic anhydride and 100 mM triethanolamine at room temperature for 10 min, washed by sequential incubations in DEPC-treated 70% ethanol at room temperature for 15 s, DEPC-treated 80% ethanol at room temperature for 15 s, DEPC-treated 90% ethanol at room temperature for 15 s, DEPC-treated 100% ethanol at room temperature for 15 s twice, and dried. The sections were preincubated in a hybridization buer (50% formamide, 200 mg/ml tRNA, 16Denhardt's solution, 10% dextran sulphate, 0.6 M NaCl, 0.25% SDS, 10 mM Tris-Cl, 1 mM EDTA, pH 7.6) at 858C for 10 min, and incubated with a 1 mg/ml DIG-labelled ribonucleotide probe in the hybridization buer at 508C for 16 h. The sections were washed by sequential incubations in 50% formamide, 26SSC at 508C for 15 min twice, TNE solution (0.5 M NaCl, 10 mM Tris-Cl, 1 mM EDTA, pH 8.0) at 378C for 10 min, 10 mg/ml RNaseA in TNE solution at 378C for 10 min, TNE solution at 378C for 10 min, 26SSC at 508C for 20 min twice, and 0.26SSC at 508C for 20 min. The sections were visualized by anti-DIG antibody staining according to a manufacturer's protocol (Roche Diagnostics, Mannheim, Germany).
Cell culture and transient transfection assays
293 and 293T cells were grown in Dulbecco's modi®ed Eagle's medium with 10% foetal bovine serum plus antibiotics. Transfection of these cells was performed using a standard calcium phosphate mediated method (Sambrook et al., 2001) . For single transfection assays, 1610 6 cells per 6 cm dish were transfected with a total of 5 mg of DNA.
Antibodies and growth factors
Anti-Myc 9E10 monoclonal antibody (mAb) was from Santa Cruz Biotechnology (Santa Cruz, CA, USA), anti-V5 mAb from Invitrogen (Carlsbad, CA, USA) and anti-Flag from Sigma (St Louis, MO, USA). IL-1 (interleukin-1) was purchased from Promega (Madison, WI, USA).
Immunoprecipitation and Western blotting
For immunoprecipitation studies, cells were lysed in lysis buer containing 50 mM Tris, pH 7.6, 150 mM NaCl, 1% Nonidet P-40, in the presence of protease inhibitors (1 mM phenylmethylsulfonyl¯uoride, 1 mM Na 3 VO 4 , 1 mM NaF and 1 mg/ml each of aprotinin, leupeptin and pepstatin). The cell lysate was centrifuged at 15 000 r.p.m. for 4 min. The supernatant was served as cell lysate. The cell lysates were incubated with the respective antibodies against epitope tags, at the concentration recommended by the manufacturer, and 15 ml of a 50% slurry of protein G-Sepharose (Amersham Pharmacia) for 2 h to overnight. The mixtures were centrifuged at 15 000 r.p.m. for 2 min. The pellets were washed three times and subjected to SDS ± PAGE (polyacrylamide gel electrophoresis).
Kinase assays
Kinase activities in the immune complexes were examined using myelin basic protein (MBP, from Sigma) as a kinase substrate for PAK5 and GST ± ATF2 for JNK and p38. The cells were lysed in kinase assay lysis buer (50mM Tris, pH 7.6, 150 mM NaCl, 1% Nonidet P-40, 10 mM sodium uoride, 5 mM b-glycerophosphate and 1 mM sodium orthovanadate plus protease inhibitors). The downstream kinase was ®rst immunoprecipitated by incubating the lysates with the appropriate antibody against the epitope for 4 h with 15 ml of 50% slurry of Protein A/G-conjugated sepharose beads (Amersham-Pharmacia). The immunoprecipitates were washed twice in lysis buer, followed by two washes in assay dilution buer (ADB) ± 20 mM MOPS pH 7.2, 10 mM b-glycerophosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM dithiothreitol and 10 mM sodium¯uoride. Five mg of MBP or dephosphorylated GST ± ATF-2 (Upstate Biotechnology, Lake Placid, NY, USA) was then added along with 10 ml of ATP/MgCl 2 mix (500 mM of unlabelled ATP, 75 mM MgCl 2 in ADB) and 1 ml of [g-32 P]-labelled ATP (5000 Ci/mmol) in a total reaction volume of 50 ml. The samples were incubated for 15 min at 308C to permit the phosphorylation of the substrates, followed by addition of SDS sample loading buer. The samples were subsequently boiled for 5 min and loaded onto an SDS ± PAGE gel followed by autoradiography.
GST pulldown assays
GST-fusion proteins were by sonicating the bacterial pellet obtained after induction with 1 mM IPTG in of lysis buer (50 mM Tris, pH 7.6, 150 mM NaCl, 1% Nonidet P-40, 1 mM sodium orthovanadate plus protease inhibitors). After sonication, the samples were centrifuged and supernatants incubated with glutathione-sepharose beads (Sigma, St. Louis, MO, USA) in PBS for 2 h. Fifty ml of glutathione sepharose slurry with immobilized GST-fusion proteins was washed three times in activation buer (50 mM HEPES ± NaOH, pH 7.4, 100 mM KCl, 1 mM DTT). After the last wash, 100 ml buer was left in the tube and GTP added to 2 mM, followed by incubation at 378C for 4 min. The activation reaction was then stopped by addition of MgCl 2 to a ®nal concentration of 20 mM. For pulldown assays, 293T cells were transfected with WT PAK5 or DCRIB constructs and 36 h after transfection, the cells were lysed. Clari®ed lysates were incubated with 50 ml of unloaded or GTP-loaded GST-fusion protein and incubated for 4 h at 48C. Beads were then washed three times in lysis buer, boiled in SDS sample buer for 5 min, separated by SDS ± PAGE and subjected to Western blotting.
